A pairing appears on this page only when a trial gave both ingredients together and measured the result. Lanolin has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Almost every non-vegan vitamin D3 on the market starts as sheep wool wax. The 7-dehydrocholesterol fraction is separated from lanolin, irradiated with ultraviolet light to open the B ring, and thermally isomerised to cholecalciferol. The finished D3 contains no lanolin, which is why it clears a wool allergy concern but not a vegan one. This is the single most important relationship lanolin has in supplements.
Lanolin-derived D3 is a crystalline solid with almost no water solubility. Dissolving it in a medium-chain triglyceride carrier puts it into the mixed micelle phase the small intestine actually absorbs from. Softgels use this for a reason, and dry tablets taken without any fat are the weaker case. The oil is the vehicle, not an active.
Lanolin-derived D3 raises calcium absorption from the gut, while K2 is the cofactor for carboxylating the matrix Gla protein and osteocalcin that direct where calcium is deposited. Formulators pair them because the two steps sit at opposite ends of the same handling chain. They share the same lipid vehicle, which makes the combination straightforward to make. The pairing is formulation convention backed by clear biochemistry.
Cholecalciferol from lanolin is inert until two hydroxylation steps run, one in the liver and one in the kidney. Both enzymes require magnesium, as does the vitamin D binding protein interaction. Low magnesium status means a dose gets converted less efficiently. This is textbook cofactor biochemistry, not a marketing pairing.
Lanolin-sourced D3 is what makes dietary calcium usable, by upregulating the transport machinery in the duodenum. Calcium taken without adequate vitamin D status is absorbed at a much lower fraction. The two are co-dosed for exactly this reason. Combining them says nothing about bone density on its own.
Lanolin works as a semi-occlusive layer that slows water loss from the skin surface. Hyaluronic acid works from the other direction by holding water in the upper layers. A humectant applied without something above it can dry out in low humidity, which is where the occlusive matters. This is skin formulation practice, not systemic biology.
Lanolin's sterol esters and branched fatty acids sit on the surface and reduce transepidermal water loss. Ceramides are structural lipids of the stratum corneum itself. Products combine them to address the barrier at two levels. Evidence for the combination specifically is thinner than evidence for either alone.
Neat lanolin is tacky and heavy, which limits where people will use it. Squalane is light and spreads easily, so blending it cuts the drag without removing the occlusive effect. This is a texture decision made by the formulator. Neither ingredient changes the other's chemistry.
Oxidised lanolin is more irritating than fresh lanolin, and the free lanolin alcohols released by oxidation are the fraction most often linked to contact sensitivity. Adding tocopherol to the fat phase slows peroxide formation during shelf life. This protects tolerability rather than adding any activity. It is why grade and freshness matter more than concentration.
Nothing specific on file for Lanolin. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 3 we read for Lanolin. The full linked list is below.
7 sources behind our Lanolin verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Read this carefully. These are 2,967 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Lanolin is, not how risky it is. A report is not proof Lanolin caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.